SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBio-Sustainable Future Enterprises Regulatory News (BSFA)

Share Price Information for Bio-Sustainable Future Enterprises (BSFA)

Share Price is delayed by 15 minutes
Get Live Data
1.125    -0.875 (-43.75%)
Bid:
1.00
Ask:
1.25
Spread: 0.25 (25.00%)
Market Cap: £1.88m
BSFA Live PriceLast checked at - London Stock Exchange

Intraday Bio-Sustainable Future Enterprises Share Chart

Lab-Grown Leather Ltd Progress

21 May 2025 07:00

RNS Number : 4970J
BSF Enterprise PLC
21 May 2025
 

 

 

London, 21 May 2025

 

BSF Enterprise PLC 

 

Lab-Grown Leather Ltd Progress

 

BSF Enterprise PLC (LSE:BSFA) a leading innovator in tissue-engineered materials is pleased to announce significant progress in its 100% owned subsidiary, Lab-Grown Leather Ltd ("LGL"), a pioneer in the development of sustainable, high-quality, lab-grown leather. LGL is applying its patented advanced tissue engineering platform (ATEP™) to create leather alternatives for high-value markets, including luxury goods, aerospace, and automotive.

Product Development Highlights

LGL is developing three core product lines:

Elemental Leather™: Premium, high-end luxury leather, identical in feel, look, and smell to traditional leather. It is 100% lab-grown, free of scaffolds and additives.

Elemental+™: High-performance, lightweight, and thin new-age leather.

Elemental X™: Novel leather enabled by engineering biology, AI, and a proprietary cell expression system. This includes the groundbreaking T-Rex leather.

Elemental+™: New Ultra-Thin and Strong Leather

LGL has achieved a significant breakthrough with Elemental+™. Traditional animal leather loses integrity and strength when processed below 0.4mm. However, Elemental+™ can be produced at an astonishing thickness of just 0.04mm - a hundred times thinner than the thickest traditional leather-while maintaining comparable strength and durability. This has been achieved using vegetable-derived tanning components, making it more environmentally friendly. This innovation, and associated new patent filing, opens new possibilities for applications in sectors where weight is critical, such as sportswear, electric vehicles, and aerospace.

Dr Che Connon of Lab-Grown Leather Ltd. stated, "Elemental+™ is a testament to the power of our Advanced Tissue Engineering Platform and our commitment to pushing the boundaries of what biofabricated materials can achieve. We've engineered a new form of leather that retains the desirable properties of traditional leather while offering a level of thinness and strength previously unattainable. This opens up entirely new design and functional possibilities for industries where every gram counts."

Elemental X: T-Rex Leather

LGL has also made substantial progress with Elemental X™, including the development of T-Rex leather. This world-first material, to be derived from synthetic T-Rex DNA, has garnered significant media attention. The leather will be grown in LGL's facilities in Newcastle upon Tyne, UK. Unlike other producers, LGL's finished leather contains no synthetic scaffolds or plastics. Elemental X leather can be made from unlimited species types (past or present). In collaboration with The Organoid Company and VML, a subsidiary of WPP plc, we will promote and scale the Lab-Grown T-Rex Leather product. Given its unique nature and limited initial availability, T-Rex leather is expected to be exclusive and priced at a substantial premium.

Media around the announcement has been a global hit covering an audience of over 500M, a 2.5M estimated print circulation, 38 individual articles and over 2.5K likes, comments and shares on social media platforms, with a predicted view of 1.75M

Following this we have had 3 commercial conversations with new leads in fashion and accessories which are ongoing with a view to partnering to produce the world first T-rex leather product.

Traditional Leather Partnerships

LGL in 2025 has established a working partnership with another significant fashion brand and is currently continuing to work with three other major fashion brands. These brands are paying LGL to produce samples for assessment and development. Progress is being made confidently, albeit at a measured pace, with these samples being tested and assessed.

To date eight 10x10cm2 samples have been sent out this year to multiple companies, as part of an iterative process their supportive feedback has resulted in notable improvements to the Elemental LeatherTM product to further improve the look, feel and suitability for down-stream processing.

Continuous improvement

LGL production plans are set for significant growth and 3DBT's City-Mix™ media additive will offer substantial savings. Over next 5 years the purchase and use of City-Mix™ from 3DBT will save Lab-Grown Leather Ltd over £500k in tissue production costs, helping to further bring down the cost of the Elemental Leather™ whilst representing an additional revenue stream for 3DBT.

 

Contact Information For further information, please visit: www.bsfenterprise.com

 

 

For further enquiries, please visit www.bsfenterprise.com or contact:

 

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPUMUAUPAPPU
Date   Source Headline
12th Jun 20267:00 amRNSParis Auction Result
11th Jun 20267:00 amRNS£1 Million Convertible Loan Note
8th Jun 202611:59 amRNSShareholder meeting results
3rd Jun 20267:00 amRNSConditional Further Investment
2nd Jun 20268:50 amRNSTechnical White Paper on T-Rex Leather™
28th May 20267:00 amRNSAuction Update - May 2026
26th May 20267:00 amRNSStrategic Update May 2026
22nd May 20263:13 pmRNSPosting of Circular and Notice of General Meeting
5th May 20267:00 amRNST-Rex Leather™ handbag to be auctioned
17th Apr 202610:00 amRNSAdmission of Shares
13th Apr 20267:00 amRNSStrategic Shareholding Update
7th Apr 20267:00 amRNSWorld’s First T-Rex Leather Handbag Unveiled
2nd Apr 20267:00 amRNSWorld First T-Rex Leather™ Product
19th Mar 20267:00 amRNSSupply Agreement with SeaWith
17th Mar 20267:00 amRNSLGL Tanning Milestones
17th Mar 20267:00 amRNSLGL Tanning Milestones
13th Mar 20267:00 amRNSFurther Update on Fundraise & Reorganisation
13th Mar 20267:00 amRNSFurther Update on Fundraise & Reorganisation
10th Mar 202610:47 amRNSFirst Tannable A4-Sized Skin Achieved
10th Mar 202610:47 amRNSFirst Tannable A4-Sized Skin Achieved
3rd Mar 202611:00 amRNSResult of Annual General Meeting
27th Feb 20267:00 amRNSUpdate on Proposed Equity Fundraise
9th Feb 20267:00 amRNSNotice of 2026 AGM
3rd Feb 20265:14 pmRNSAnnual Financial Report - Correction
2nd Feb 20267:00 amRNSAnnual Financial Report
19th Jan 20267:00 amRNSKERATO LIMITED SIGNS WITH QUEBEC PSO GRANT
17th Dec 202511:08 amRNSResult of General Meeting
16th Dec 20257:00 amRNS3D Bio-Tissues Signs Supply Agreement with SeaWith
15th Dec 20257:00 amRNSChanges to timetable for proposed Equity Fundraise
5th Dec 20259:50 amRNS-RBSF Enterprise launches new Investor website
1st Dec 20257:02 amRNSProposed Equity Fundraise - Strategic Direction
1st Dec 20257:00 amRNSEquity Fundraise & Notice of General Meeting
29th Aug 202510:47 amRNSResignation of Chairman
10th Jul 20257:00 amRNSAgreement
25th Jun 20257:00 amRNSInterim 2025 Results
23rd May 20257:00 amRNS15p Warrants Amended
21st May 20257:00 amRNSLab-Grown Leather Ltd Progress
28th Apr 202510:01 amRNSStrategic Investment
25th Apr 20259:48 amRNSJoint Venture
13th Mar 20257:00 amRNS3DBT Lab Grown Leather Commercialization
6th Mar 20253:51 pmRNSPublication of a Prospectus
5th Mar 202512:10 pmRNSResult of Annual General Meeting
11th Feb 20258:21 amRNSExpected admission of shares - Replacement
11th Feb 20257:00 amRNSAIM Admission - Update
10th Feb 20257:00 amRNSAGM Statement
31st Jan 202512:41 pmRNSAnnual Financial Report
31st Jan 202512:31 pmRNSAnnual Financial Report
21st Jan 20257:00 amRNSBSF Enterprise and Sartorius
27th Dec 20247:00 amRNSAdmission of Placing Shares
18th Dec 20247:00 amRNS3DBT Ltd Secures Prestigious Northern Accelerator

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.